Market Forecast By Prescription Type (Prescription Drugs, Over-the-Counter Drugs), By Drug Type (Branded Drugs, Generic Drugs, Branded Generic Drugs), By Drug Class (Small Molecules, Biologics, Biosimilars), By Indication (Cardiovascular Diseases, Immunology, Respiratory Diseases, Neurological Diseases, Infectious Diseases, Skin Diseases), By Mode of Administration (Topical, Oral, Injectable, Intra-nasal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
| Product Code: ETC7767128 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights, the Jordan Pharmaceutical Market is projected to grow at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2032.
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Years | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 4.7 | Robust domestic pharmaceutical manufacturing and export activity. |
| 2022 | 5 | Increasing demand for affordable generics and prescription medicines. |
| 2023 | 5.2 | Increased treatment demand for cardiovascular and respiratory diseases. |
| 2024 | 5.4 | Expansion of hospital infrastructure and specialist care services. |
| 2025 | 5.6 | Growth in biosimilars adoption and regional export opportunities. |
The Jordan Pharmaceutical Market report thoroughly covers the market by prescription type, drug type, drug class, indication, mode of administration, and distribution channel. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | Jordan Pharmaceutical Market |
| Forecast period | 2026–2032 |
| CAGR | 5.6% |
| Growing Sector | Generic Drugs |
Jordan Pharmaceutical Market is anticipated to undergo robust growth supported by a well-established domestic pharmaceutical manufacturing base, increasing healthcare demand, and increasing export-oriented production. The country serves as a regional pharmaceutical hub, providing medicines to multiple Middle Eastern and North African markets, which solidifies industry scale and capacity utilization. Furthermore, growing incidence of cardiovascular, respiratory, and neurological diseases is bolstering the demand of long-term prescription medicine.
Below mentioned are some prominent drivers and their influence on the Jordan Pharmaceutical Market
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Strong Domestic Manufacturing | Generic Drugs, Branded Generics | Supports cost-friendliness and export competitiveness. |
| Rising Chronic Disease Burden | Prescription Drugs | Raises the demand of long-term therapy. |
| Hospital Infrastructure Expansion | Hospital Pharmacies | Boosts inpatient and specialist volume of medicines. |
| Biosimilars Adoption | Biosimilars | Improves access to advanced therapies at controlled costs. |
| Export Market Growth | All Segments | Solidifies the scale of production scale and stability of the industry. |
The Jordan Pharmaceutical Market is projected to grow at a CAGR of 5.6% from 2026 to 2032. Market growth is encouraged by increasing consumption of prescription medicines, robust reliance on generic and branded generic drugs, and growing volume of hospital procurement. Jordan’s role as a regional pharmaceutical exporter and its emphasis on quality manufacturing further augments long-term market stability. Additionally, rising adoption of biosimilars and continued allocation of money in production capacity expansion are predicted to support sustained market growth.
Below mentioned are some major restraints and their influence on the Jordan Pharmaceutical Market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| Pricing Controls | Branded Drugs | Limits pricing flexibility and margins. |
| Regulatory Compliance Costs | Manufacturers | Increases operational expenses. |
| Import Dependency for APIs | All Segments | Supply chain and price risks. |
| Competition in Export Markets | Generic Drugs | Solidifies the costing pressure. |
| Limited Specialty Drug Access | Biologics | Decreases penetration of developed therapies. |
Jordan Pharmaceutical Industry goes through challenges consisting of pricing regulations, reliance on imported raw materials, and increasing competition in regional export markets. Regulatory compliance costs and quality certification requirements add operational complexity for manufacturers. Ensuring cost-friendless while expanding access to advanced biologics and biosimilars persists to be a major challenge for industry stakeholders.
Several notable trends are shaping the Jordan Pharmaceutical Market dynamics:
Some notable investment opportunities in the Jordan Pharmaceutical Industry include:
Below is the list of prominent companies leading in the market:
| Company Name | Hikma Pharmaceuticals |
|---|---|
| Established Year | 1978 |
| Headquarters | Amman, Jordan |
| Official Website | Click Here |
Hikma is a dominant pharmaceutical manufacturer with robust presence in generics and injectables. The company encourages both domestic supply and international exports.
| Company Name | Jordan Pharmaceutical Manufacturing (JPM) |
|---|---|
| Established Year | 1962 |
| Headquarters | Naor, Jordan |
| Official Website | Click Here |
JPM supplies branded and generic medicines across multiple therapeutic areas, encouraging the demand of regional healthcare.
| Company Name | Dar Al Dawa Development & Investment Co. |
|---|---|
| Established Year | 1975 |
| Headquarters | Amman, Jordan |
| Official Website | Click Here |
Dar Al Dawa emphasis on premium quality generics and exports to international markets, solidifying Jordan’s pharmaceutical footprint.
| Company Name | Arab Pharmaceutical Manufacturing (APM) |
|---|---|
| Established Year | 1989 |
| Headquarters | Al-Salt, Jordan |
| Official Website | Click Here |
APM manufactures prescription medicines and encourages cost-friendly healthcare solutions across the region.
| Company Name | Pharmaceutical Manufacturing Co. (PMC) |
|---|---|
| Established Year | 1994 |
| Headquarters | Zarqa, Jordan |
| Official Website | Click Here |
PMC emphasis on branded generics and specialty formulations, encouraging the demand of chronic disease therapy.
According to Jordanian government data, the pharmaceutical market is regulated by national authorities overseeing drug registration, pricing, quality control, and distribution. Government initiatives concentrates on promoting domestic manufacturing, ensuring affordability of medicines, and promoting exports. Regulatory frameworks also focusses on quality compliance that meets with international standards to solidify worldwide market access.
Jordan Pharmaceutical Market Growth is expected to witness steady increase bolstered by robust domestic manufacturing, increasing incidence of chronic disease, and growing export opportunities. Continued investment in biosimilars, API localization, and hospital infrastructure will strengthen long-term market development. Government support for pharmaceutical exports and quality compliance is expected to further enhance industry competitiveness.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Vasudha, Senior Research Analyst, 6Wresearch, prescription drugs lead the Jordan Pharmaceutical Market Share owing to physician-led treatment protocols and increasing incidence of chronic diseases needing continuous monitoring. Robust hospital and specialist care services further encourage the demand of prescription medicine.
Generic drugs hold the largest market share as Jordan focusses cost-effective treatments encouraged by robust domestic manufacturing capabilities.
Small molecules lead due to broad use in cardiovascular, respiratory, neurological, and infectious disease treatments and also established manufacturing processes and cost-friendliness contribute to increased adoption rates.
Cardiovascular diseases lead due to increasing incidence rates and long-term therapy requirements. Persistent demand for antihypertensive and cardiac medicines sustains this segment’s leadership.
Oral formulations leads due to ease of administration, robust patient compliance, and suitability for the treatment of long-term outpatient.
Retail pharmacies lead due to broad geographic presence and their part as the primary dispensing channel for chronic and routine prescriptions.
The report offers a comprehensive study of the following Jordan Pharmaceutical Market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Jordan Pharmaceutical Market Overview |
| 3.1 Jordan Country Macro Economic Indicators |
| 3.2 Jordan Pharmaceutical Market Revenues & Volume, 2022 & 2032F |
| 3.3 Jordan Pharmaceutical Market - Industry Life Cycle |
| 3.4 Jordan Pharmaceutical Market - Porter's Five Forces |
| 3.5 Jordan Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2022 & 2032F |
| 3.6 Jordan Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
| 3.7 Jordan Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
| 3.8 Jordan Pharmaceutical Market Revenues & Volume Share, By Indication, 2022 & 2032F |
| 3.9 Jordan Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
| 3.10 Jordan Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
| 4 Jordan Pharmaceutical Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing prevalence of chronic diseases in Jordan |
| 4.2.2 Growing healthcare infrastructure and government initiatives to improve access to healthcare services |
| 4.2.3 Rising disposable income and changing lifestyles leading to higher demand for pharmaceutical products |
| 4.3 Market Restraints |
| 4.3.1 Stringent regulatory requirements and approval processes for pharmaceutical products |
| 4.3.2 Limited healthcare budget and reimbursement policies impacting the affordability of medicines |
| 5 Jordan Pharmaceutical Market Trends |
| 6 Jordan Pharmaceutical Market, By Types |
| 6.1 Jordan Pharmaceutical Market, By Prescription Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 Jordan Pharmaceutical Market Revenues & Volume, By Prescription Type, 2022- 2032F |
| 6.1.3 Jordan Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2022- 2032F |
| 6.1.4 Jordan Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2022- 2032F |
| 6.2 Jordan Pharmaceutical Market, By Drug Type |
| 6.2.1 Overview and Analysis |
| 6.2.2 Jordan Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2022- 2032F |
| 6.2.3 Jordan Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2022- 2032F |
| 6.2.4 Jordan Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2022- 2032F |
| 6.3 Jordan Pharmaceutical Market, By Drug Class |
| 6.3.1 Overview and Analysis |
| 6.3.2 Jordan Pharmaceutical Market Revenues & Volume, By Small Molecules, 2022- 2032F |
| 6.3.3 Jordan Pharmaceutical Market Revenues & Volume, By Biologics, 2022- 2032F |
| 6.3.4 Jordan Pharmaceutical Market Revenues & Volume, By Biosimilars, 2022- 2032F |
| 6.4 Jordan Pharmaceutical Market, By Indication |
| 6.4.1 Overview and Analysis |
| 6.4.2 Jordan Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2022- 2032F |
| 6.4.3 Jordan Pharmaceutical Market Revenues & Volume, By Immunology, 2022- 2032F |
| 6.4.4 Jordan Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2022- 2032F |
| 6.4.5 Jordan Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2022- 2032F |
| 6.4.6 Jordan Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2022- 2032F |
| 6.4.7 Jordan Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2022- 2032F |
| 6.5 Jordan Pharmaceutical Market, By Mode of Administration |
| 6.5.1 Overview and Analysis |
| 6.5.2 Jordan Pharmaceutical Market Revenues & Volume, By Topical, 2022- 2032F |
| 6.5.3 Jordan Pharmaceutical Market Revenues & Volume, By Oral, 2022- 2032F |
| 6.5.4 Jordan Pharmaceutical Market Revenues & Volume, By Injectable, 2022- 2032F |
| 6.5.5 Jordan Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2022- 2032F |
| 6.5.6 Jordan Pharmaceutical Market Revenues & Volume, By Others, 2022- 2032F |
| 6.6 Jordan Pharmaceutical Market, By Distribution Channel |
| 6.6.1 Overview and Analysis |
| 6.6.2 Jordan Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2022- 2032F |
| 6.6.3 Jordan Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2022- 2032F |
| 6.6.4 Jordan Pharmaceutical Market Revenues & Volume, By Drug Stores, 2022- 2032F |
| 6.6.5 Jordan Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2022- 2032F |
| 7 Jordan Pharmaceutical Market Import-Export Trade Statistics |
| 7.1 Jordan Pharmaceutical Market Export to Major Countries |
| 7.2 Jordan Pharmaceutical Market Imports from Major Countries |
| 8 Jordan Pharmaceutical Market Key Performance Indicators |
| 8.1 Average prescription fill rate |
| 8.2 Number of pharmacies offering a wide range of pharmaceutical products |
| 8.3 Patient adherence rate to prescribed medication |
| 8.4 Percentage of population covered by health insurance |
| 8.5 Investment in research and development by pharmaceutical companies in Jordan |
| 9 Jordan Pharmaceutical Market - Opportunity Assessment |
| 9.1 Jordan Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2022 & 2032F |
| 9.2 Jordan Pharmaceutical Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
| 9.3 Jordan Pharmaceutical Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
| 9.4 Jordan Pharmaceutical Market Opportunity Assessment, By Indication, 2022 & 2032F |
| 9.5 Jordan Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
| 9.6 Jordan Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
| 10 Jordan Pharmaceutical Market - Competitive Landscape |
| 10.1 Jordan Pharmaceutical Market Revenue Share, By Companies, 2022-2032F |
| 10.2 Jordan Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |